ArticleJournal of cancer research and clinical oncology2012

In vitro and in vivo anti-tumor activities of anti-EGFR single-chain variable fragment fused with recombinant gelonin toxin.

Xikun Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.